SUPPLEMENT

FY2024 — Additional analyst information

FY2024PDF · 15 pages695 KB
This pack has been prepared to aid discussion and provide further
supplementary information only and has not been subject to an
external review or audit

-- 1 of 15 --

CUSTOMERS PER ENTITY
Life Policyholders
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	449 211 	449 300 	447 690 	449 130 	449 020 	449 378 	448 313 	445 813 	446 713 	452 561 	446 475
Invest
Invest - DRO 	137 503 	137 718 	137 189 	135 819 	134 721 	133 741 	132 817 	131 244 	129 606 	127 831 	124 135
Invest - Other 	229 871 	225 414 	221 273 	216 479 	212 161 	206 778 	201 210 	195 231 	192 615 	189 210 	185 025
Group (lives) 	711 051 	707 756 	711 161 	680 754 	584 081 	562 769 	576 450 	562 440 	578 035 	551 219 	544 443
Group schemes 	2 616 	2 647 	2 663 	2 666 	2 793 	2 844 	2 827 	2 825 	2 797 	2 740 	2 771
Life NB APE
12 months to 	6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to
R million 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	2 778 	1 444 	2 663 	1 355 	2 362 	1 204 	2 072 	1 068 	2 126 	1 165 	2 215
Group 	164 	75 	175 	130 	181 	64 	193 	94 	160 	75 	97
Invest - Recurring 	1 673 	851 	1 551 	796 	1 428 	737 	1 167 	573 	1 164 	686 	1 221
Invest - Single APE1 	1 627 	778 	1 500 	708 	1 493 	782 	1 570 	744 	1 508 	671 	1 382
Total Life APE 	6 242 	3 148 	5 889 	2 990 	5 464 	2 786 	5 001 	2 478 	4 958 	2 597 	4 915
1 APE shown at 10% of Single premium
Health Members
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
DHMS - Keycare 	207 934 	226 848 	225 517 	232 988 	232 055 	234 421 	235 841 	230 960 	232 714 	243 046 	240 140
DHMS - Non-Keycare 	1 152 395 	1 147 016 	1 149 861 	1 142 556 	1 135 853 	1 118 591 	1 111 545 	1 099 553 	1 111 079 	1 108 674 	1 110 401
In-House Schemes 	354 944 	321 333 	319 813 	321 838 	318 246 	316 973 	321 613 	321 767 	319 974 	317 408 	316 410
Total 	1 715 273 	1 695 197 	1 695 191 	1 697 382 	1 686 154 	1 669 985 	1 668 999 	1 652 280 	1 663 767 	1 669 128 	1 666 951
Health Lives
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
DHMS - Keycare 	350 038 	385 906 	384 759 	398 397 	397 595 	401 307 	404 984 	400 108 	403 392 	420 869 	415 436
DHMS - Non-Keycare 	2 394 452 	2 402 336 	2 413 851 	2 412 595 	2 406 528 	2 383 486 	2 375 082 	2 358 232 	2 381 735 	2 387 237 	2 394 336
In-House Schemes 	798 933 	710 485 	707 406 	710 427 	704 472 	699 342 	707 293 	704 749 	698 534 	689 688 	686 114
Total 	3 543 423 	3 498 727 	3 506 016 	3 521 419 	3 508 595 	3 484 135 	3 487 359 	3 463 089 	3 483 661 	3 497 794 	3 495 886
Vitality SA
June 2024 	December 2023 	June 2023 December 20222 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Total Vitality Health,
Vitality Drive and Vitality
Money programme lives
2 922 347 	2 822 972 	2 652 877 	2 498 048 	2 348 834 	2 242 401 	2 163 411 	2 122 453 	2 065 868 	2 060 011 	1 987 237
2 restated to include for LA wellness figures
VitalityHealth Members
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	140 400 	138 278 	135 117 	129 568 	124 395 	117 007 	113 189 	108 955 	105 915 	104 997 	101 702
SME 	340 983 	327 876 	310 624 	285 865 	263 216 	238 540 	222 961 	211 949 	212 305 	209 509 	201 960
Corporate 	120 685 	112 941 	108 191 	102 823 	99 578 	89 881 	86 149 	80 514 	81 124 	78 050 	70 583
Trust and Cost Plus 	20 237 	16 448 	16 339 	14 511 	8 698 	3 944 	2 731 	2 639 	- 	- 	-
Total 	622 305 	595 543 	570 271 	532 767 	495 887 	449 372 	425 030 	404 057 	399 344 	392 556 	374 245
VitalityHealth Lives
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	260 210 	256 527 	250 551 	238 629 	227 684 	212 896 	204 890 	195 996 	188 976 	186 559 	179 811
SME 	541 111 	522 753 	496 299 	460 442 	429 110 	395 777 	374 179 	357 768 	356 907 	353 763 	342 431
Corporate 	191 015 	178 163 	171 364 	163 120 	158 890 	148 654 	143 905 	135 218 	135 440 	131 991 	120 157
Trust and Cost Plus 	35 163 	27 349 	26 854 	22 673 	15 903 	6 509 	4 066 	3 956 	- 	- 	-
Total 	1 027 499 	984 792 	945 068 	884 864 	831 587 	763 836 	727 040 	692 938 	681 323 	672 313 	642 399
VitalityLife Policies
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Policies 	679 382 	646 564 	622 451 	593 322 	565 778 	535 281 	517 913 	493 970 	474 890 	458 675 	434 678
VitalityLife Lives
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Lives3 	810 050 	782 296 	764 699 	735 137 	702 105 	669 139 	647 020 	617 051 	594 799 	577 965 	549 526
3 restated to include unique lives only
Discovery Insure Policies
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Policies 	214 297 	215 297 	211 223 	214 315 	213 453 	212 570 	202 335 	191 936 	178 517 	169 920 	159 171
Discovery Bank
June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Primary Clients 	958 055 	825 069 	702,131 	581 457 	470 220 	385 177 	331 088 	287 183 	206 810 	61 731 	1 476
Total Accounts 	2 271 703 	1 933 839 	1,625,912 	1 312 970 	1 023 790 	793 215 	648 546 	521 081 	357 416 	141 660 	3 740
2 Membership

-- 2 of 15 --

VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE
June 2024
VNB at Point of Sale
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Acquisition Costs and Initial strain 	(550) 	(2 833) 	(1 560) 	(1 132) 	(6 075)
Value of In Force 	1 653 	3 393 	2 051 	1 074 	8 171
Cost of Capital 	(52) 	(79) 	(63) 	(70) 	(264)
1 051 	481 	428 	(128) 	1 832
New business contribution to value of in force at valuation date
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Value of In Force 	1 615 	2 454 	1 906 	909 	6 884
Cost of Capital 	(51) 	(79) 	(60) 	(68) 	(258)
1 564 	2 375 	1 846 	841 	6 626
December 2023
VNB at Point of Sale
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Acquisition Costs and Initial strain 	(253) 	(1 452) 	(754) 	(635) 	(3 094)
Value of In Force 	659 	1 739 	999 	535 	3 932
Cost of Capital 	(21) 	(45) 	(53) 	(35) 	(154)
385 	242 	192 	(135) 	684
New business contribution to value of in force at valuation date
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Value of In Force 	660 	1 256 	960 	513 	3 389
Cost of Capital 	(21) 	(45) 	(52) 	(28) 	(146)
639 	1 211 	908 	485 	3 243
June 2023
VNB at Point of Sale
R million 	Health and Vitality Life and Invest 	VitalityHealth 	VitalityLife 	Total
Acquisition Costs and Initial strain 	(485) 	(2 757) 	(1 885) 	(1 845) 	(6 972)
Value of In Force 	1 439 	3 273 	2 154 	1 848 	8 714
Cost of Capital 	(39) 	(87) 	(87) 	(89) 	(302)
915 	429 	182 	(86) 	1 440
New business contribution to value of in force at valuation date
R million 	Health and Vitality Life and Invest 	VitalityHealth 	VitalityLife 	Total
Value of In Force 	1 434 	2 575 	1 745 	1 907 	7 661
Cost of Capital 	(38) 	(87) 	(95) 	(95) 	(315)
1 396 	2 488 	1 650 	1 812 	7 346
With respect to VitalityLife, the "Acquisition Costs and Initial Strain" and "Value of In-Force" for the VNB at Point of Sale have been restated in prior periods to correctly reflect total acquisition
costs and initial commission net of FinRe receivables, with an equal and opposite adjustment to the “Value of In Force”. The Net VNB at Point of Sale for prior periods remains unchanged.
3 Value of New Business

-- 3 of 15 --

EV RECONCILIATION TO INCOME STATEMENT
for the year ended 30 June 2024
R million
Embedded
Value Earnings
Value of
In-Force
Cost of
required
Capital
Impact on
Income
Statement
Adjustment to
Shareholders
Funds
Statement of
Changes in
Equity
Total profit from new business 	1 832 	6 609 	(264) 	(4 513) 	- 	-
- Health and Vitality 	1 051 	1 543 	(52) 	(440) 	- 	-
- Life 	481 	2 310 	(79) 	(1 750) 	- 	-
- VitalityHealth 	428 	1 843 	(63) 	(1 352) 	- 	-
- VitalityLife 	(128) 	913 	(70) 	(971) 	- 	-
Profit from existing business
* Expected return 	10 340 	2 716 	(72) 	7 696 	- 	-
- Health and Vitality 	3 809 	675 	7 	3 127 	- 	-
Expected transfer from VIF to net worth 	- 	(3 127) 	- 	3 127 	- 	-
Unwinding of the risk discount rate 	3 809 	3 802 	7 	- 	- 	-
- Life 	4 596 	2 742 	(1) 	1 855 	- 	-
Expected transfer from VIF to net worth 	- 	(1 855) 	- 	1 855 	- 	-
Unwinding of the risk discount rate 	4 596 	4 597 	(1) 	- 	- 	-
- VitalityHealth 	911 	(784) 	(46) 	1 741 	- 	-
Expected transfer from VIF to net worth 	- 	(1 741) 	- 	1 741 	- 	-
Unwinding of the risk discount rate 	911 	957 	(46) 	- 	- 	-
- VitalityLife 	1 024 	83 	(32) 	973 	- 	-
Expected transfer from VIF to net worth 	- 	(973) 	- 	973 	- 	-
Unwinding of the risk discount rate 	1 024 	1 056 	(32) 	- 	- 	-
* Change in methodology and assumptions 	2 385 	1 050 	1 117 	218 	- 	-
- Health and Vitality 	(787) 	(821) 	34 	- 	- 	-
- Life 	479 	(1 142) 	(13) 	1 634 	- 	-
- VitalityHealth 	588 	284 	304 	- 	- 	-
- VitalityLife 	2 105 	2 729 	792 	(1 416) 	- 	-
- 	-
* Experience variances 	564 	1 049 	- 	(485) 	- 	-
- Health and Vitality 	429 	59 	(3) 	373 	- 	-
- Life 	(40) 	334 	2 	(376) 	- 	-
- VitalityHealth 	305 	746 	31 	(472) 	- 	-
- VitalityLife 	(130) 	(90) 	(30) 	(10) 	- 	-
Increase in goodwill and intangibles 	(308) 	- 	- 	- 	(308) 	-
Other initiatives 	1 088 	24 	- 	1 064 	- 	-
Non-recurring expenses 	(96) 	- 	- 	(96) 	- 	-
Acquisition costs 	(33) 	(1) 	- 	(32) 	- 	-
Finance costs 	(2 796) 	- 	- (2 796) 	- 	-
Other 	2 	- 	- 	- 	2 	-
Foreign Exchange Rate Movements 	(1 555) 	(1 095) 	43 	437 	170 	(1 110)
Intangibles 	147 	- 	- 	- 	147 	-
DAC 	23 	- 	- 	- 	23 	-
Other 	(1 725) 	(1 095) 	43 	437 	- (1 110)
Return on shareholders' funds 	1 585 	- 	- 	1 523 	- 	62
Unrealised gain on investments and realised gain on investments
transferred to income statement 865 	- 	- 	803 	- 	62
Health and Vitality investment income 	106 	- 	- 	106 	- 	-
Life investment income 	614 	- 	- 	614 	- 	-
VitalityHealth investment income 	- 	- 	- 	- 	- 	-
VitalityLife investment income 	- 	- 	- 	- 	- 	-
Amortisation of Intangibles 	(60) 	- 	- 	(435) 	375 	-
Amortisation of intangibles from business combinations 	(60) 	- 	- 	(91) 	31 	-
Amortisation of systems intangibles 	- 	- 	- 	(344) 	344 	-
VitalityHealth and VitalityLife DAC and unemployment reserve 	- 	- 	- 	271 	(271) 	-
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 	- 	- 	- 	(129) 	129 	-
Life assets under insurance contracts 	- 	- 	- 	2 931 	(2 931) 	-
VitalityLife net assets under insurance contracts 	- 	- 	- 	1 616 	(1 616) 	-
Equity settled share based payment mark-to-market adjustment 	- 	- 	- 	94 	(94) 	-
Embedded value earnings 	12 948 	10 352 	824 	7 364 	(4 544) 	(1 048)
Adjustment to Shareholders' Funds:
Change in: *
DAC 	655
Intangibles & Goodwill 	204
Life negative reserve 	5 626
VitalityLife negative reserve 	737
1 DP IFRS 16 financial lease accounting 	129
Equity settled share based payment mark-to-market adjustment 	(94)
* The change in the adjustments to shareholder’s funds is a on a consistent IFRS 17 basis between 30 June 2024 and 30 June 2023. The reported change in adjustment to shareholder’s funds for 30 June
2023 and prior (in the Group EV Statement) is on an IFRS 4 basis.
4 EV recon

-- 4 of 15 --

EV BUILD-UP PER ENTITY
for the year ended 30 June 2024
R million Health and Vitality Life and Invest VitalityHealth VitalityLife 	Other 	Total
Value of in-force business at 30 June 2023 	25 473 	31 636 	12 099 	10 682 	- 	79 890
Expected return (in-force business) 	3 721 	4 457 	826 	996 	- 	10 000
Release of profits (in-force business) 	(3 127) 	(1 855) 	(1 741) 	(973) 	- 	(7 696)
Value of new business 	1 601 	3 314 	1 988 	981 	- 	7 884
Expected return (new business) 	88 	139 	85 	28 	- 	340
Release of profits (new business) 	(110) 	(1 083) 	(208) 	(138) 	- 	(1 539)
Experience variances 	56 	336 	777 	(120) 	- 	1 049
Methodology changes 	(787) 	(1 155) 	588 	3 521 	- 	2 167
Other 	(1) 	24 	(510) 	(542) 	- 	(1 029)
Value of in-force business at 30 June 2024 	26 914 	35 813 	13 904 	14 435 	- 	91 066
Shareholders’ funds per Balance Sheet 	4 449 	30 000 	9 184 	4 122 	9 964 	57 719
Adjustment to shareholders' funds 	- 	(19 865) 	(4 351) 	(11 322) 	(2 893) 	(38 431)
Embedded value at 30 June 2024 	31 363 	45 948 	18 737 	7 235 	7 071 	110 354
5 EV Buildup per Entity

-- 5 of 15 --

COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO
SHAREHOLDERS' FUNDS ON PUBLISHED BASIS
R million 	June 2024
1. Assets under insurance contracts
Discovery Life positive liabilities not netted off with negative liabilities: 	627
Discovery Life long term reserves in respect of policies with net negative liabilities: 	(30 717)
Working capital 	148
Discovery Life liability for incurred claims (LIC) 	7 619
Total Assets under insurance contracts: 	(22 323)
2. Negative liabilites not included under assets under insurance contracts
Negative reserve in respect of Invest business 	(7 011)
DAC and DRL in respect of Invest business 	(768)
(7 779)
3. Components to be zeroised based on the Method of Distributable Cashflows:
Discovery Life long term reserves in respect of policies with net negative liabilities: 	(30 717)
Liabilities under reinsurance contracts** 	258
Negative reserve in respect of Invest business 	(7 011)
DAC and DRL in respect of Invest business 	(768)
Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 	6 165
Liabilities off set against Negative reserve before zeroisation 	12 208
(19 865)
** This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the
method of distributable cashflows.
4. Other adjustments to published Shareholders' funds
VitalityLife net assets under insurance contracts 	(11 314)
VitalityHealth and VitalityHealth Insurance Limited deferred acquisition costs (net of deferred tax) 	(4 351)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) 	(8)
Goodwill 	(2 855)
Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance
Company joint venture (803)
Net preference share capital 	(779)
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 	1 462
Equity settled share based payment mark-to-market adjustment 	82
Adjustment to Shareholders' funds from published basis 	(38 431)
6 EV Adjustment to SH funds

-- 6 of 15 --

RECONCILIATION TO THE REQUIRED CAPITAL
for the year ended 30 June 2024
R million Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Opening - 30 June 2023 	1 108 	26 011 	4 238 	10 630 	41 987
- Methodology and Basis Changes 	- 	(223) 	(369) 	1 684 	1 092
- Expected release on in-force at start of period 	(45) 	(448) 	(200) 	(465) 	(1 158)
- Impact of new business written 	197 	848 	520 	1 346 	2 911
- Other changes* 	(22) 	1 747 	112 	(1 436) 	401
- Exchange rate movements 	- 	- 	(163) 	(460) 	(623)
Change in Required Capital 	130 	1 924 	(100) 	669 	2 623
Closing - 30 June 2024 	1 238 	27 935 	4 138 	11 299 	44 610
*This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required
capital. This component of the expected yield curve unwind is shown separately from the expected release for information purposes only.
For VitalityLife, this line includes the release of the 1.5 times the UK Solvency I long-term insurance capital requirement, with an allowance for
the diversification or risk, associated with the VitalityLife business on the PAC license.
7 Recon of Required Capital

-- 7 of 15 --

BREAKDOWN OF INVEST ASSETS UNDER ADMINISTRATION
R million 	Total
December 2021 	127 632
June 2022 	121 737
December 2022 	130 830
June 2023 	140 378
December 2023 	144 810
June 2024 	154 653
8 Invest AUA

-- 8 of 15 --

SA 	SA 	SA 	SA 	SA 	UK 	UK ALL OTHER SEGMENT 	IFRS
R million 	HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL 	TOTAL
30 June 2024
Income statement
Insurance revenue 	435 	17 249 	4 360 	5 737 	- 	16 474 	6 904 	698 	51 857 	- 	51 857
- Contracts measured under the General measurement model/Variable fee approach 	- 	13 741 	4 360 	- 	- 	- 	6 904 	- 	25 005 	- 	25 005
- Contracts measured under Premium allocation approach 	435 	3 508 	- 	5 737 	- 	16 474 	- 	698 	26 852 	- 	26 852
Insurance service expenses 	( 341) (15 235) 	(2 671) 	(5 471) 	- (15 456) 	(6 217) 	( 754) (46 145) 	- (46 145)
- Claims and benefits 	( 224) (12 104) 	( 462) 	(3 540) 	- 	(9 562) 	(3 098) 	( 472) (29 462) 	- (29 462)
- Insurance service expense and other 	( 54) 	(1 124) 	(1 148) 	(1 069) 	- 	(4 127) 	( 509) 	( 135) 	(8 166) 	- 	(8 166)
- Insurance acquisition cash flows 	( 63) 	(2 007) 	(1 061) 	( 862) 	- 	(1 767) 	(2 610) 	( 147) 	(8 517) 	- 	(8 517)
Insurance service result (pre-reinsurance) 	94 	2 014 	1 689 	266 	- 	1 018 	687 	( 56) 	5 712 	- 	5 712
Net income/(expenses) from reinsurance contracts 	( 1) 	( 458) 	- 	( 24) 	- 	( 8) 	( 408) 	( 16) 	( 915) 	- 	( 915)
- Reinsurance expense 	( 1) 	(3 692) 	- 	( 474) 	- 	( 8) 	(5 738) 	( 275) (10 188) 	- (10 188)
- Insurance claims recovered from reinsurers 	- 	3 234 	- 	450 	- 	- 	5 330 	259 	9 273 	- 	9 273
Insurance service result 	93 	1 556 	1 689 	242 	- 	1 010 	279 	( 72) 	4 797 	- 	4 797
Net financial result from insurance finance income and expense 	- 	2 674 	(9 850) 	- 	- 	- 	231 	- 	(6 945) 	( 300) 	(7 245)
- Net finance income/(expense) from insurance contracts 	- 	2 869 	(9 850) 	- 	- 	- 	379 	- 	(6 602) 	( 300) 	(6 902)
- Net finance expense from reinsurance contracts 	- 	( 195) 	- 	- 	- 	- 	( 148) 	- 	( 343) 	- 	( 343)
Investment income earned on assets backing policyholder liabilities 	- 	22 	49 	209 	- 	175 	65 	22 	542 	318 	860
Net fair value (losses)/gains on financial instruments at fair value through profit or loss 	( 6) 	971 	10 098 	1 	1 	60 	- 	1 401 	12 526 	3 719 	16 245
Fair value adjustments to liabilities under investment contracts 	- 	( 1) 	( 738) 	- 	- 	- 	- 	(1 403) 	(2 142) 	- 	(2 142)
Third party interest: fair value adjustments to liabilities under investment contracts 	- 	- 	- 	- 	- 	- 	- 	- 	- 	(2 873) 	(2 873)
Intersegment funding 	( 13) 	( 169) 	169 	13 	- 	- 	- 	- 	- 	- 	-
Other gains and losses on financial instruments 	- 	- 	- 	- 	5 	- 	- 	- 	5 	- 	5
Net investment and financial results 	74 	5 053 	1 417 	465 	6 	1 245 	575 	( 52) 	8 783 	864 	9 647
Fee income from administration businesses 	9 233 	- 	1 712 	- 	- 	54 	- 	3 094 	14 093 	- 	14 093
Vitality income 	- 	- 	- 	- 	- 	640 	264 	3 751 	4 655 	- 	4 655
Net banking fee and commission income 	- 	- 	- 	- 	1 367 	- 	- 	31 	1 398 	- 	1 398
- Banking fee and commission income 	- 	- 	- 	- 	1 872 	- 	- 	- 	1 872 	- 	1 872
- Banking fee and commission expense 	- 	- 	- 	- 	( 505) 	- 	- 	31 	( 474) 	- 	( 474)
Net bank interest and similar income 	- 	- 	- 	- 	779 	- 	- 	- 	779 	- 	779
- Bank interest and similar income using the effective interest rate 	- 	- 	- 	- 	1 840 	- 	- 	- 	1 840 	- 	1 840
- Bank interest and similar expense using the effective interest rate 	- 	- 	- 	- 	(1 061) 	- 	- 	- 	(1 061) 	- 	(1 061)
Other income 	1 173 	3 	- 	16 	- 	42 	- 	86 	1 320 	60 	1 380
Non-insurance revenue and income 	10 406 	3 	1 712 	16 	2 146 	736 	264 	6 962 	22 245 	60 	22 305
Net income 	10 480 	5 056 	3 129 	481 	2 152 	1 981 	839 	6 910 	31 028 	924 	31 952
Acquisition costs 	- 	- 	( 880) 	- 	- 	- 	- 	( 108) 	( 988) 	- 	( 988)
Expected credit losses 	- 	- 	- 	- 	( 183) 	- 	- 	- 	( 183) 	- 	( 183)
Marketing and administration expenses 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
- depreciation and amortisation 	( 171) 	- 	( 17) 	( 72) 	( 339) 	( 465) 	( 49) 	( 822) 	(1 935) 	( 224) 	(2 159)
- derecognition of intangible assets and property and equipment 	- 	- 	- 	( 16) 	- 	( 1) 	- 	( 38) 	( 55) 	- 	( 55)
- impairment of intagible assets and property and equipment 	- 	- 	- 	- 	- 	( 13) 	- 	( 9) 	( 22) 	- 	( 22)
- other expenses 	(6 337) 	( 291) 	( 710) 	( 194) 	(2 084) 	(1 065) 	( 421) 	(6 164) (17 266) 	( 142) (17 408)
Share of net profits from equity-accounted investments 	- 	- 	- 	49 	- 	( 2) 	6 	972 	1 025 	( 50) 	975
Normalised profit/(loss) from operations 	3 972 	4 765 	1 522 	248 	( 454) 	435 	375 	741 	11 604 	508 	12 112
Fair value losses on VitalityLife interest rate derivatives 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
Investment income earned on shareholder investments and cash 	120 	27 	16 	- 	- 	- 	- 	155 	318 	( 318) 	-
Intercompany investment income 	- 	- 	- 	- 	- 	- 	- 	1 046 	1 046 	(1 046) 	-
Net fair value (losses)/gains on financial assets at fair value through profit or loss 	- 	87 	75 	- 	- 	- 	- 	- 	162 	( 162) 	-
Gain/(Loss) from dilution of equity accounted investments 	- 	- 	- 	22 	- 	- 	- 	- 	22 	- 	22
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
Impairment of goodwill 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
Amortisation of intangibles from business combinations 	- 	- 	- 	( 49) 	- 	- 	- 	( 56) 	( 105) 	105 	-
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
Market rentals related to Head Office building adjusted for finance costs and depreciation 	- 	- 	- 	- 	- 	- 	- 	( 105) 	( 105) 	105 	-
Restructuring costs 	- 	- 	- 	- 	- 	- 	- 	( 48) 	( 48) 	48 	-
Interest expenses on borrowings and lease liabilities 	( 2) 	( 1) 	- 	- 	- 	( 17) 	( 217) 	(1 513) 	(1 750) 	( 286) 	(2 036)
Intercompany finance expenses on borrowings 	( 412) 	- 	- 	- 	- 	- 	( 464) 	( 170) 	(1 046) 	1 046 	-
Foreign exchange gains/(losses) 	( 6) 	( 11) 	( 20) 	- 	- 	- 	- 	( 50) 	( 87) 	- 	( 87)
Profit/(loss) before income tax 	3 672 	4 867 	1 593 	221 	( 454) 	418 	( 306) 	- 	10 011 	- 	10 011
Income tax expense 	( 987) 	(1 314) 	( 339) 	( 58) 	171 	( 144) 	25 	( 1) 	(2 647) 	- 	(2 647)
Profit/(loss) for the year 	2 685 	3 553 	1 254 	163 	( 283) 	274 	( 281) 	( 1) 	7 364 	- 	7 364
Profit attributable to:
- Ordinary shareholders 	2 695 	3 553 	1 254 	163 	( 283) 	274 	( 281) 	( 92) 	7 283 	- 	7 283
- Preference shareholders 	- 	- 	- 	- 	- 	- 	- 	91 	91 	- 	91
- Non-controlling interest 	( 10) 	- 	- 	- 	- 	- 	- 	- 	( 10) 	- 	( 10)
Segment information
IFRS
REPORTING
ADJUSTMEN

-- 9 of 15 --

VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST
R million 	June 2024 December 2023 	June 2023 December 2022 	June 2022
VIF1
Life 	24 138 	22 859 	22 244 	23 133 	22 059
Invest 	11 675 	10 429 	9 393 	9 521 	8 505
APE2
Life 	804 	426 	823 	463 	837
Invest 	2 411 	1 150 	2 142 	1 033 	2 158
VNB1
Life 	225 	136 	162 	169 	364
Invest 	256 	106 	267 	160 	341
1 These VIF and VNB numbers are after allowing for the Cost of required Capital.
2 APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium Investment business) in
relation to New Business only, and excludes any addition to Existing Business premiums arising from servicing increases and
ACIs.
Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for December 2016 and later
periods.
10 Results split Life and Invest

-- 10 of 15 --

Group Shareholder Free Cash Movement
R millions 	FY2024 	HY2024 	FY2023 	HY2023
Cash Generated from In-Force Before Financing and Tax1,2 	14 617 	7 567 	14 425 	6 903
New Business2 	(6 823) 	(3 528) 	(7 243) 	(3 408)
Tax Paid 	(1 522) 	(792) 	(1 839) 	(1 042)
Operating cash flow 	6 272 	3 247 	5 343 	2 453
New Initiatives 	(1 025) 	(776) 	(1 671) 	(800)
Business Development and Other 	(1 580) 	(864) 	(1 274) 	(434)
Finance Cost Paid 	(1 566) 	(802) 	(1 501) 	(786)
Dividends Paid 	(1 270) 	(783) 	(69) 	(31)
Financing and Matching Initiatives2 	(496) 	(332) 	166 	150
Transactions with Borrowers (Excl. Finance Costs)1 	1 130 	(80) 	(597) 	(463)
Movement in Shareholder Free Cash 	1 465 	(390) 	397 	89
Remove ordinary shareholder dividend paid in shareholder cash flow period 	1 178 	740 	- 	-
Add ordinary shareholder dividend paid in respect of shareholder cash flow period 	(1 467) 	(439) 	(740) 	-
Movement in Shareholder Free Cash – Dividend Accrual Basis3 	1 176 	(89) 	(343) 	89
Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period
R millions 	FY2024 	HY2024 	FY2023 	HY2023
Profit for the period 	7 364 	3 343 	5 320 	2 943
Reverse non-cash profit items:
Share of net profits/(losses) from equity accounted investments 	(1 031) 	(302) 	(561) 	(76)
Gains from dilution of equity accounted investments 	(22) 	- 	5 	-
Depreciation and amortisation 	2 160 	1 040 	1 972 	957
Impairment of intangible assets 	45 	4 	61 	4
Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) 	(42) 	(14)
Movement in contract assets 	(640) 	(252) 	52 	31
Amortisation of intangibles from business combinations 	- 	- 	56 	27
Non cash impact of Vitality Health DAC 	(411) 	(206) 	(753) 	(292)
Non-cash fair value gains on financial assets 	(87) 	(56) 	(214) 	(43)
Non-cash forex gains / losses 	- 	- 	9 	(1)
Other non-cash adjustments to profit1 	(152) 	(64) 	(178) 	(44)
Adjustments from IFRS to EV ANW:
Increase in Negative Reserves and Invest DAC (Net of tax) 	(4 547) 	(1 767) 	(4 141) 	(1 735)
Exchange rate movements on Vitality Life Negative Reserves 	(385) 	(137) 	1 900 	195
Other adjustments to arrive at EV ANW4 	1 644 	137 	196 	104
Incurred to Cash basis:
- Rent Paid 	(511) 	(286) 	(328) 	(158)
- Finance Costs Paid 	(2 603) 	(802) 	(1 501) 	(932)
- Finance Costs Accrued 	3 097 	1 025 	1 941 	930
- Taxation paid 	(1 522) 	(792) 	(1 839) 	(1 042)
- Taxation Accrued 	1 093 	810 	1 495 	741
Investing Activities:
Purchase of property and equipment 	(414) 	(246) 	(551) 	(210)
Proceeds from disposal of property and equipment 	28 	2 	2
Purchase of intangible assets 	(1 789) 	(800) 	(1 760) 	(751)
Increase in investment in associate 	287 	(176) 	(75) 	(53)
Acquisition of business net of cash required 	- 	- 	(3) 	-
Financing Activities:
Increase in borrowings 	2 005 	500 	7 441 	3 855
Repayment of borrowings1 	(874) 	(580) 	(8 038) 	(4 318)
Dividends paid to ordinary shareholders 	(1 179) 	(739) 	- 	-
Dividends paid to preference shareholders 	(91) 	(44) 	(69) 	(31)
Movement in Shareholder Free Cash 	1 465 	(390) 	397 	89
Notes
"Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in
working capital are not allowed for in the estimate.
1) HY2023 and FY2023: Reallocation of rental paid on finance leases from "Transactions with Borrowers" to "Cash Generated from In-Force". This value was immaterial in all other periods.
2) Prior to FY2024 "Financing and Matching Initiatives", previously disclosed as "Transactions with Reinsurers", included the net external FinRe cash flows for VitalityLife. From FY2024, and restated for prior periods, the
net external FinRe cash flows for VitalityLife have been reallocated to "Operating Cash Flow", with FinRe repayments included in "Cash Generated from In-Force Before Financing and Tax" and new FinRe receivables
offset against "New Business".
3) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For the year ended 30 June 2024, the interim declared dividend of
R439m, per the interim financial results, and the final declared dividend of R1 028m, per the annual financial results, are used as the total dividend accrued in respect of the twelve-month period.
4) For FY2024, this adjustment considers the VitalityLife modelling change which reallocated the capitalised impact of deferred tax relief on future earnings between adjusted net worth and value of in-force. This
modelling change impacts the EV adjusted net worth, but is not considered a shareholder cash flow impact, and is therefore reversed from the Movement in Shareholder Free Cash Flow build-up.

-- 11 of 15 --

Reconciliation of operating profit to normalised operating profit
for the year ended 30 June 2024
Group Group
Year
ended
June 2024
Year
ended
June 2024
R million 	change
Operating profit 	11 137 	10 308 	8%
Share of net profits from equity accounted investments 	975 	525
Impairment of goodwill 	- 	9
Normalised profit from operations per Segment information (IFRS total) 	12 112 	10 842 	12%
Normalised profit adjustments 	( 508) 	( 925)
Investment income earned on shareholder investments and cash 	( 318) 	( 216)
Difference between market related rental and depreciation and finance costs (Head office) 	( 181) 	( 157)
Net fair value gains on financial assets at fair value through profit or loss 	( 162) 	( 138)
VitalityLife interest rate derivative 	- 	( 516)
Amortisation of intangibles from business combinations 	105 	102
Restructuring costs 	48 	-
Normalised profit from operations 	11 604 	9 917 	17%
12 Op Profit recon

-- 12 of 15 --

NAV PER ENTITY
for the year ended June 2024
Covered businesses 	June 2024
NAV before adjustment to shareholder funds
Health and Vitality 	4 449
Life and Invest 	30 000
VitalityHealth 	9 184
VitalityLife 	4 122
Non-covered business
Bank, including DCS intangible asset and goodwill 	7 773
Insure 	2 060
PAHI 	6 225
CMT 	1 561
Limited 	(11 517)
Other 	3 863
Total NAV 	57 719

-- 13 of 15 --

RMB million (except lives) 	June 2024 June 2023 Change
New business PAHI own licence (100%) 	3 842 	3 428 	12%
New business PAHI Reinsurance 	533 	289 	84%
New business PAHI total (100%) 	4 375 	3 717 	18%
Written premium-own licence 	16 118 14 318 	13%
Written premium-reinsurance 	6 527 	5 314 	23%
Total written premium (100%) 	22 645 19 632 	15%
Earned premiums – Total 	15 320 14 281 	7%
Total investable assets 	23 328 19 869 	17%
Lives-own licence 	27 	22 	26%
Lives-reinsurance 	8 	6 	26%
Total lives 	35 	28 	26%
PAHI profit before income and gains (100%) 	1 470 	881 	67%
PAHI investment income and gains (100%) 	621 	456 	36%
PAHI pre-tax profit (100%) 	2 092 	1 337 	56%

-- 14 of 15 --



-- 15 of 15 --